Category: Press Release

The Lantern Project from Sanofi Genzyme and PerkinElmer Expands Access to Free Diagnostic Genetic Testing for a Number of Lysosomal Storage Disorders

November 1, 2018  |  Press Release

CAMBRIDGE, Mass., Oct. 15, 2018 /PRNewswire/ -- Patients with rare genetic diseases can face a difficult path to a proper diagnosis. Because there is a lower awareness...

Read Full Press Release

Enzyvant Announces Collaboration with PerkinElmer to Enable Diagnostic Testing for Farber Disease

July 19, 2018  |  Press Release

BASEL, Switzerland and WALTHAM, Mass., July 19, 2018 /PRNewswire/ -- Enzyvant, a biopharmaceutical company focused on developing innovative treatments for people living with rare diseases, today announced that it...

Read Full Press Release

PerkinElmer Collaborates with Helix to Drive Innovation in Exome-Based Personal Genomics

April 10, 2018  |  Press Release

First Personal Genomics Product Will Focus on 59 Genes Identified by the American College of Medical Genetics and Genomics (ACMG) as Highly Penetrant April 10,...

Read Full Press Release

Parent Project Muscular Dystrophy Selects PerkinElmer to Support Decode Duchenne Program

April 5, 2018  |  Press Release

April 05, 2018 08:15 AM Eastern Daylight Time WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that Parent...

Read Full Press Release

Neuromuscular Disease Foundation (NDF) Launches Whole Genome Sequencing Research for Rare Muscle Disease

December 21, 2017  |  Press Release

BEVERLY HILLS, CALIF. (PRWEB) DECEMBER 21, 2017 The Neuromuscular Disease Foundation (NDF) - the world's leading nonprofit organization focused on the rare genetic disease called GNE...

Read Full Press Release

Where are you located?